Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
That is all the official record says: SeLux Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
No investor of SeLux Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 27 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by SeLux Diagnostics, Inc.
Name
Role
Named in
Adam Parker Steel
Executive officer
Feb 2024
Aleksandar E. Vacic
Executive officer
Feb 2024
Eric E. Stern
Executive officer
Feb 2024
John Parker Wilson
Executive officer
Feb 2024
Michele Parker Healy
Executive officer
Feb 2024
Steven E. Lufkin
Executive officer
Feb 2024
Jack Parker Percoskie
Executive officer
Feb 2022
Jack E. Percoskie
Executive officer
Jun 2021
Vacic E. Alexander
Executive officer
Jun 2021
Eric E. Stern
Director
Feb 2024
Erich Parker Scheller
Director
Feb 2024
Ingo Parker Chakravarty
Mr. Chakravarty was elected Director upon the Date of First Sale.